BioHouston

BioHouston Blog

Thu, 15 May 2008 17:48:23 GMT

M. D. Anderson Receives $35 Gift for Cancer Prevention May 15, 2008 The Dan L. Duncan Family Foundation has given The University of Texas M. D. Anderson Cancer Center $35 million—the institution’s largest gift to the cancer prevention program and its second-largest gift in its 67-year history. The funds will be used to establish the Dan Duncan Family Institute for Cancer Prevention and Risk Assessment. The Duncan family’s generosity will enable M. D. Anderson to study the incidence and determinants of cancer in medically underserved and minority communities. A major element of the Duncan Family Institute will address cancer-related behavioral and genetic risk factors in medically underserved communities to better develop cancer prevention strategies and ultimately reduce cancer-related deaths in this rapidly growing segment of our population. The gift also will allow M. D. Anderson to recruit additional researchers and clinicians to implement new or enhance current...

Board of Directors

Wed, 14 May 2008 21:55:36 GMT

Executive Committee Chairman Malcolm Gillis, Ph.D. University Professor and Ervin K. Zingler Professor of Economics Rice University Welcome Letter Vice-Chairman John Mendelsohn, M.D. President The University of Texas M.D. Anderson Cancer Center Secretary and Treasurer Bruce Given, M.D. Healthcare Products Consultant Bruce Given Consulting Steven C. Currall, Ph.D. Vice Dean of Enterprise, Professor and Head (Chair) of Department of Management Science and Innovation, Faculty of Engineering Sciences, University College London; Visiting Professor of Organisational Behaviour and Entrepreneurship (Joint appointment with University College London), Faculty Co-Director, Institute of Technology, London...

BioHouston Breakfast Forum

Wed, 14 May 2008 21:48:57 GMT

June 24, 2008
7:30 AM - 9:00 AM

M. D. Anderson South Campus Research Building II

7435 Fannin Street

Houston, TX 77054

Save the date!

Our featured speaker for the June Breakfast Forum is Huda Zoghbi, M.D., Professor at Baylor College of Medicine and Investigator at Howard Hughes Medical Institute.

Dr. Zoghbi research interests include genetic and cell biological approaches to explore the pathogenesis of Rett syndrome and autistic spectrum disorders, polyglutamine neurodegenerative diseases, and to study genes essential for normal neurodevelopment.

More details to come soon!

Sponsorship for the June and August Breakfast Forum available...please contact Keisha Curtis at 713-979-9212.

Capital Development

Tue, 13 May 2008 21:58:44 GMT

Houston is the home to the largest medical center in the world. With over $1.5 billion in annual academic research investments and over 140 life science companies, the region has attracted venture capitalists from across the nation to invest in the growing life science industry in Houston. Texas has also become a hot spot for venture capital investments as a result of the recent approval of the $3 bilion cancer research insitute by Governor Rick Perry, which will distribute up to $300 million in annual grants over the next decade. Listed below are resources for biotech firms, ranging from funds to relevant conferences. Texas Emerging Technology Fund Gulf Coast RCIC Match-Making Meetings SBIR/STTR Support for Emerging Companies Venture Capital Firms National Industry Conferences S3 Ventures is an early-stage technology investor focusing...

BioHouston Newsletter

Fri, 09 May 2008 14:02:04 GMT

BioHouston Newsletter--May 9, 2008 Events & Announcements Breakfast Forum--Texas Newest Venture Fund - Santé Ventures presents The Early Stages of Venture Capital in Texas--May 14--Sponsored by Mayer Brown LLP Life Science Technology Venture Forum--May 15, 2008 BioProducts: Coming Down the Pipeline, A Texas Opportunity--May 21-22 Association of Bioscience Financial Officers National Conference--June 3-6 BIO International Convention--June 17-20 Advances in Tissue Engineering 2008--August 13 - 16--BioHouston members receive discounted registration BioPharm America 2008--September 9-10 Mark your calendars for the 2008 Texas Life Science Conference--November 5, 6, & 7--Sponsorship opportunities available...please contact Keisha Curtis at 713.979.9212 2008 Christopher Columbus Fellowship Foundation $25,000 Homeland Security Award--Nominations due May 23rd News Updates ULURU Inc. Announces the Launch Plan for Altrazeal(TM) ArthroCare...

Members & Associates

Mon, 05 May 2008 21:15:01 GMT

We are grateful to our members and contributors for their generous suppport. All of BioHoustons events and programs are designed to benefit our member institutions and strengthen life science companies in the Houston area. We are happy to report that our membership is growing as more contributors join us to build Houstons life science industry. Many of your colleagues have already joined BioHouston as Members or Associates. We represent more than 120 biotechnology and life science companies, academic institutions, healthcare orgnaizations, service providers and philanthropic organizations in the Houston region. The organization is growing by leaps and bounds as the people of Houston realize the importance of this developing economic engine for the region. We are helping to lead the most innovative and dynamic industry in the world by helping our Members and Associates find continuing success and opportunities. We invite you to join us in helping to create a vibrant life science...

Associate Advisory Board

Mon, 05 May 2008 21:13:21 GMT

Dawn Miller AIG Ngu Morcho AlphaDev Mark Shumbera Aptamed Paul R. Morico Baker Botts LLP Charles Szalkowski Baker Botts LLP Meg Boulware Baker McKenzie LLP Gray Hancock British Consulate-General Laura Capper CAP Resources Gwen Wagner CenterPoint Energy Steven M. Plumb Clear Financial Solutions, Inc. Michael E. Novelli Cypressbrook Company Dan Watkins, Ph.D. DFJ Mercury Debbie Pennington Economic Development Alliance for Brazoria County Carole Faig Ernst & Young LLP Jim Meador Fairway Medical Technologies John M. Farrell FKP Architects, Inc. Michael Clements Frost...

Education & Workforce

Fri, 02 May 2008 18:32:58 GMT

Texas in Top 5 Regions in the World for Biotechnology As one of the top 5 regions in the world for biotechnology, the presence of life science careers in Texas is growing, especially in the Houston region. Home to the Texas Medical Center, Houston has the largest medical center in the world and offers a wide range of educational opportunities and careers in the life sciences. Need a job? Click here to search our job board. Looking to fill open positions? Click here. EDUCATION The institutions in the Houston/Galveston offers extensive programs in biodefense and infectious disease, cardiovascular medicine, genetics/genomics, nanotechnology, and oncology. If you are unsure of what path to take in your career in the life sciences, visit H.O.T. Jobs to view position that is best for you. Specific points include: areas of specialization licensure certification educational programs work environment length of tranining professional associations ...

5th Annual Chili Cook-Off

Fri, 04 Apr 2008 16:00:35 GMT

March 28, 2008 12:00 PM - 5:00 PM BioHouston Offices 2555 Holly Hall Street This years teams brought tons of food to share with attendees, including turkey legs, hot dogs,, kabobs, fruit plates, sausage on a stick, and more! Getting ready for the Chili Cook-Off... Encysive Pharmaceuticals wins Best Booth for Survivor Encysive Having fun in the limbo contest Dan Monticello (far left), President of Molecular LogiX, poses with his team, Chili LogiX Janel Wang of Pharmaceutical Services Corporation, PSChili, poses for the camera Setting up for the jalapeño eating contest Cooling down with milk and water after a competitive contest of jalapeño eating! Janet Varela of Kelly Scientific Resources, Kellys Crows Nest Chili, enjoying the Cook-Off This years Chili Cook-Off saw several four-legged friends who also enjoyed the event, especially the many hot dogs and sausages that coincidentally fell on the ground We are grateful to our...

BioHouston Resource Center (BRC)

Thu, 20 Mar 2008 17:40:51 GMT

THE BIOHOUSTON RESOURCE CENTER Start-ups today need to generate data demonstrating the commercial potential of their products to access significant funding sources. More than ever, start-ups need access to facilities and resources to develop their projects and generate data to get to the next funding event. Without accessible facilities, start-up companies expend scarce resources on leasing and building out laboratory space, purchasing furniture and equipment, and busying themselves with starting up and managing a life science lab. Located one mile south of the Texas Medical Center, the BioHouston Resource Center (BRC) makes it easier and more affordable for start-up companies to walk into the lab and get to work producing data, by providing access to wet lab bench space, shared equipment, and the offices and tools that start-up companies need. The BioHouston Resource Center is constantly seeking lab equipment, materials, and monetary donations. If you would like to donate...

Why Join BioHouston?

Thu, 20 Mar 2008 17:38:43 GMT

WHY JOIN BIOHOUSTON? Many of your colleagues have already joined BioHouston as Members or Associates. We represent more than 120 biotechnology and life science companies, academic institutions, healthcare orgnaizations, service providers and philanthropic organizations in the Houston region. The organization is growing quickly as the people of Houston realize the importance of this developing economic engine for the region. We are helping to lead the most innovative and dynamic industry in the world by helping our Members and Associates find continuing success and opportunities. Benefits of joining BioHouston are myriad -- prominent exposure to key people in the industry through more than 80 networking events annually, discounted registration rates to BioHouston events, and much more. For more information, please click here. WHO SHOULD JOIN? All components of the life science industry are encouraged to become members of BioHouston. Our membership ranges from research...

VC Networking

Wed, 19 Mar 2008 19:11:49 GMT

This meeting is an evening networking opportunity for our area life science venture capitalists, principal investors, the staffs of technology transfer offices, and life science company CEOs. The meetings provide these individuals the chance to meet in a more informal setting than our monthly technology transfer luncheons. Normally, a speaker provides a brief overview of a scientific area of compelling interest as a conversation starter.

Open only to area life science venture capitalists, principal investors, the staffs of technology transfer offices, and life science company CEOs.

For more information, please contact Keisha Curtis at 713-979-9212.

Technology Transfer Luncheon

Wed, 19 Mar 2008 19:11:33 GMT

Technology Transfer LuncheonWith more than 40 institutions in the Texas Medical Center and the many additional academic, healthcare and research institutions in the region performing more than $1.4 billion in research annually, discoveries of exciting new technologies happen all the time.

The technology transfer office at each institution is the first step towards commercialization of these discoveries. To facilitate interaction between these offices and the investors and life science companies in our region, we host these monthly luncheons.

At each luncheon, a topic of discussion is chosen, and each institution will bring one or more technologies from that arena to review with the group. It may just be an early-stage discovery that has exciting potential, or it may be a patented process ready for licensing. Either way, this is a great opportunity to be in on the ground floor as the discoveries of today become the life-saving products of tomorrow.

Past Meeting Topics:

Biomarkers
Anti-infective Therapeutic and Prophylactic Vaccines
Micro-/Nanoarrays and Medical Devices, including Combination Devices
Immunotherapy
Drug Delivery Systems
Diagnostics
Devices

For more information, please contact Keisha Curtis at 713-979-9212.

CEO Dinner

Wed, 19 Mar 2008 19:11:19 GMT

The leaders of Houston region's growing biotechnology industry know the challenges of running a life science company. The CEO Dinner is an opportunity for these leaders to get to know and network with each other in a informal setting, away from the workplace and in one of Houston's finer establishments. These meetings feature a guest speaker pertinent to the industry and plenty of opportunity for networking and discussion. Open only to Life Science company CEO's, this exclusive dinner allows these executives the opportunity to frankly discuss their industry.

For more information, please contact Keisha Curtis at 713.979.9212.

CFO Networking

Wed, 19 Mar 2008 19:11:01 GMT

When it comes to maintaining the books of a life science company, you are going to need a professional with years of experience. At these periodic meetings, life science finance executives gather to discuss the challenges facing them today. All life science CFOs and finance executives are welcome to attend. CPE credit is offered to all attending.

All life science CFOs and finance executives are welcome to attend.

For more information, please contact Keisha Curtis at 713.979.9110.

Michael E. Debakey Life Science Award

Wed, 19 Mar 2008 19:10:13 GMT

The Michael E. DeBakey Award is given each year to the undiscovered life science company with the highest potential to commercialize an important product at the annual Texas Life Science Conference. The first DeBakey Award was given to ThromboVision, Inc. in 2006. Dr. DeBakey’s rich history in Houston and the Texas Medical Center, along with his pioneering spirit, truly embodies the qualities that we are seeking in future recipients of this award. Some of Dr. DeBakey’s most renowned contributions include the concept of the Mobile Army Surgical Hospitals (MASH units), performing the first successful artificial heart transplant, playing an instrumental role in the development of the Ventricular Assist Device (VAD) and being the first to successfully implant the device into a human. Additionally, he has served as consultant to almost every U.S. President in this century and received many prestigious awards, including the Presidential Medal of Freedom with Distinction, the highest...

Life Sciences Entrepreneurial Management Program

Mon, 17 Mar 2008 14:41:47 GMT

April 4 - May 3, 2008 6 Non-Consecutive Days 8:30 AM - 5:00 PM Rice University Jesse H. Jones Graduate School of Management 6100 Main Street, Houston, TX 77005 The Houston area has become a national center for the life sciences industry. Numerous start-up companies have emerged in pharmaceuticals, biotechnology, medical devices, and telemedicine. This has generated a demand for leaders with a background in both entrepreneurship and the life sciences. To educate these leaders, Rice University Executive Education, the Rice Alliance for Technology and Entrepreneurship, and BioHouston have collaborated to offer the Life Science Entrepreneurship Certificate. Participants will learn about market opportunities, intellectual property issues, life science business plans, sources of funding, and the successful launch and management of a life science start-up. Requirements for completion: The Life Science Entrepreneurship Certificate is awarded to individuals who complete all 3...

Programs & Events

Wed, 12 Mar 2008 15:17:00 GMT

BioHouston’s activities provide the greatest leverage in making the Houston region a world-class competitor in the life science industry. All of our activities are designed to: CONVENE people and organizations that need to come together to make the life science industry in Houston ignite, including scientists, intellectual property and product development experts, venture capitalists, pharmaceutical companies, and others COMMUNICATE and interact so that people and organizations can learn from one another, share information and explore opportunities CATALYZE the discoveries and commercial development so that the true potential of the life science industry in Houston can be unlocked We are deeply grateful to our many funding partners and members who are helping us fulfill our vision of building the Houston region’s life science industry into a global competitor. EVENTS BioHouston hosts over 60 events each year to nurture the criticial elements required for...

4th Annual Chili Cook-Off - April 27, 2007

Thu, 06 Mar 2008 21:02:36 GMT

Past Chili Cook-Off Events: 2007, 2006, 2005 The 4th Annual BioHouston Chili Cook-Off kicked off with over 500 attendees and 26 chili teams. The fun began at noon and lasted until 5 pm. Activities included the Polly Want a Cracker contest, limbo contest, sunflower seed spitting contest, and of course, the jalapeño eating contest. Creative tents and dressed up contestants filled the area in no time. As teams eagerly waited for the chili judging to begin, door prizes were given out, including Astros tickets, an iPod Shuffle, and restaurant gift cards, ranging from casual eateries to fine dining. Guests enjoyed hot dogs, chili, nachos, and ice cream. With local companies sponsoring the Chili Cook-Off, the event was a huge success and guests even got to take home freebies. Get ready and work on your recipes... the countdown to next years Chili Cook-Off has already begun! Getting ready for the Chili Cook-Off... Chilis cookin Let the games begin Judging time ...

2006 Annual Luncheon

Thu, 06 Mar 2008 20:58:24 GMT

Past Annual Luncheons: 2004 August 10, 2006 11:30 am - 1:30 pm Four Seasons Hotel 1300 Lamar Graciously underwritten by: On August 10, 2006 we welcomed Acting FDA Commissioner and former Houstonian Andrew C. von Eschenbach, M.D. Dr. von Eschenbach addressed the Molecular Metamorphosis that is underway and the future of biomedical research and healthcare. Dr. von Eschenbach was appointed Acting FDA Commissioner in September 2005. Prior to his appointment he served as the 12th Director of the National Cancer Institute (NCI). A nationally recognized urologic surgeon and oncologist, Dr. von Eschenbach’s distinguished career as a key leader in the fight against cancer spans nearly three decades. Other notable leadership positions include Executive Vice President and Chief Academic Officer of The University of Texas M.D. Anderson Cancer Center and the Roy M. and Phyllis Gough Huffington Clinical Research Distinguished Chair in Urologic Oncology. We are grateful...

2007 Annual Luncheon

Thu, 06 Mar 2008 20:57:26 GMT

October 18, 2007 11:30 AM to 1:30 PM InterContinental Hotel 2222 West Loop South Graciously underwritten by: The Development of the San Diego Biotechnology Cluster Ivor Royston, M.D. Co-Founder of Hybritech and Founding Managing Partner of Forward Ventures Dr. Royston is considered to be the father of biotechnology in San Diego, having co-founded Hybritech, Inc. in 1978 (later acquired by Eli Lilly) and Idec Pharmaceuticals in 1986 (which later merged with Biogen). Dr. Royston is also the founding managing partner of Forward Ventures, a leading life-science venture capital firm located in San Diego investing in pharmaceutical products and medical devices with over $500 million in capital under management. Dr. Royston has been instrumental in the formation, financing, and development of numerous successful public biotechnology companies, including: Applied Molecular Evolution (acquired by Eli Lilly); Combichem (acquired...

2006 Commercialization Symposium--The Road to Biotech Commercialization IV

Thu, 06 Mar 2008 20:56:47 GMT

The Commercialization Symposium has been integrated into the Texas Life Science Conference. For more information, please visit our page about the Texas Life Science Conference. July 18, 2006 M.D. Anderson South Campus Research Building II 7435 Fannin Graciously underwritten by: The old model of biotechnology is changing. In todays world of life science, its all about innovative techniques. BioHoustons 2006 Annual Commercialization Symposium: The Road to Commercialization IV discussed new innovative solutions from national experts on ways to build value while conserving cash and how to get your clinical data so that a private investor will invest in you. For more information, please contact Lauren Stroman at 713-979-9106. Speaker Presentations: To view presentations, click on the links below. Courtship and Consummation: An Update on Biopharma Strategic Alliance Trends Cori Gorman, Ph.D., M.B.A., Founder, DNA Bridges, Inc. Federal Grants Programs:...

2004 Texas Life Science Conference

Thu, 06 Mar 2008 20:56:14 GMT

Past Texas Life Science Conferences: 2007, 2006, 2005, 2004, Commercializaton Symposium Graciously underwritten by: 2004 Texas Life Science Conference Hits Mark in Bringing National Attention to Houston Region The 2004 Texas Life Science Conference was held November 15-17 in Houston, drawing much praise from attendees and participants alike. Designed in part to draw national awareness, the conference was a first step in a long-term process of building relationships between national VCs and the local life science community. The conference attracted more than 350 attendees, of which more than 100 were venture capitalists, half from non-Houston locations. Part of our objective for the conference is to attract the attention of the national venture capitalists, says BioHouston President & CEO, Jacqueline Northcut Waugh. With this conference, we’ve made great strides in giving them a glimpse of what’s happening in this region, from the caliber of VCs we have here to the promising...

2005 Texas Life Science Conference

Thu, 06 Mar 2008 20:55:52 GMT

Past Texas Life Science Conferences: 2007, 2006, 2005, 2004, Commercializaton Symposium Graciously underwritten by: Experience the frontier for biotechnology at the 2005 Texas Life Science Conference. BioHouston’s annual national venture capital conference took place on November 2 – 4 at The Houstonian Hotel, Club and Spa. This conference brings together the industry’s leading venture capitalists, researchers and emerging companies from across the country representing some of the most revolutionary developments in the life sciences. BioHouston also presented its Life Science Award to Tanox Inc. during the luncheon on November 3rd. Keynote Speaker: Peter G. Traber, M.D., President & CEO, Baylor College of Medicine Commercialization of Academic Life Science Discoveries The Great Debate: Does Preclinical Biopharm Investing Make Sense…and Dollars? Arthur J. Klausner, Partner, A.M. Pappas & Associates – Pro Jim Schoeneck, CEO, BrainCells, Inc. - Pro...

2006 Texas Life Science Conference

Thu, 06 Mar 2008 20:54:40 GMT

Past Texas Life Science Conferences: 2007, 2006, 2005, 2004, Commercializaton Symposium Click here to view images from the 2006 TLSC November 9 - 10, 2006 The Brown Foundation Institute of Molecular Medicine 1825 Pressler Graciously Underwritten By: The Texas Life Science Conference (TLSC), BioHouston’s annual venture capital conference, is one of most important area life science events. Held November 9 & 10th at the Institute for Molecular Medicine, this conference brings together more than 300 of the life science industry’s preeminent venture capitalists, leading researchers emerging companies executives, representing some of the most revolutionary developments in the life sciences. The TLSC showcases the region’s entrepreneurial spirit and leading start-up companies. This year, the conference showcased 18 of Texas’ most innovative and exciting companies, including finalist companies from the Emerging Technology Fund. We are especially pleased to announce...

2007 Texas Life Science Conference

Thu, 06 Mar 2008 20:53:58 GMT

Past Texas Life Science Conferences: 2007, 2006, 2005, 2004, Commercializaton Symposium The 2007 Texas Life Science Conference was a turning point event in the Houston biotechnology industry. More than 300 attendees, including the highest quality roster to date of venture capitalists from across the country, saw more than 50 companies and technologies presented at the conference. Congressional gold medal recipient and legendary heart surgeon Dr. Michael E. DeBakey presented the 2007 DeBakey Life Science Award to winner OrthoAccel Technologies, Inc. This years award was accompanied by a $25,000 cash prize. We are especially pleased to announce that 2007s keynote speaker was Jessica Chutter, Managing Director of Morgan Stanley. Jessica spoke about Trends in the Life Science Industry from an Investment Bankers Perspective Other speakers included: Chris Slavinsky, Director of Strategic Alliances at Pfizer, Inc. spoke about Trends in Successful Early Stage Partnering...

2008 Texas Life Science Conference

Thu, 06 Mar 2008 20:53:35 GMT

November 5, 6, & 7, 2008

The Brown Foundation Institute of Molecular Medicine
1825 Pressler
Houston, TX 77030

The Texas Life Science Conference is Texas' premier venture conference, the most comprehensive showcase of cutting edge research and innovative entrepreneurs in the state. The 2008 conference will build on the 2007 format, highlights of which include:

50 companies and technologies presented to over 315 conference attendees ranging from industry luminaries and key venture capitalists to leaders of emerging biotech companies, research scientists, and entrepreneurs

Over $6 billion in current funds represented by attending investors

The Michael E. DeBakey Life Science Award for the Texas undiscovered life science company with the highest potential to commercialize an important product

You won't want to miss the best of what's emerging out of Texas...mark your calendars and join us for the 2008 event!

For more information and sponsorship opportunities, please contact Keisha Curtis at 713-979-9212.

We are pleased to announce our partnership with Texas Healthcare and Bioscience Institute (THBI). This collaboration ensures representation from the most promising life science companies from across the state.

To view past Texas Life Science Conference Events, click HERE

Media Center

Wed, 05 Mar 2008 20:22:40 GMT

The BioHouston Newsletter welcomes company information and program announcements; however, all information is published at the discretion of BioHouston.

Send company news and announcements to newsletter@biohouston.org

The BioHouston Newsletter is also now accepting submissions for articles on the life science commercialization industry. Listed below are the requirements:

Must be relevant to the life science commercialization industry.
Must not endorse commercial products, services or companies.
Your submission gives BioHouston consent to publish your article in the public domain
You retain the copyrights to your article.

Send articles for consideration to newsletter@biohouston.org

Media Inquiries should be directed to Tim Graves.

Click here to sign up for the newsletter.

2nd Annual Chili Cook-Off - April 1, 2005

Wed, 05 Mar 2008 20:06:28 GMT

Past Chili Cook-Off Events: 2007, 2006, 2005

"April Foolers" win Grand Champion Chili!
Dan Monticello and Phil Pienkos with Molecular Logix, Inc. hoist the championship trophy

Six brave attendees participated in the Jalapeno Eating contest

"Booty Blasters" from Encysive Pharmacticules

Chili goers dance to music!

3rd Annual Chili Cook-Off - April 21, 2006

Wed, 05 Mar 2008 20:05:53 GMT

Past Chili Cook-Off Events: 2007, 2006, 2005 The Third Annual BioHouston Chili Cook-off was held on April 21, 2006. The fun began at noon and went until 6 PM. Thanks to all our 375 attendees and 27 chili teams for coming together as a life science community and having fun with activities including Frisbee golf, caricature artists, and made-to-order ice cream. Our area venture capitalists and media representatives once again served as our official judges. Underwritten by: Genesis Biotechnology Park Introgen Therapeutics 2006 Chili Cook-off Winners Grand Champion Chili Lexicons Knockout Chili Headquarters Jalapeno Eating Champ Naomi Puhl--Introgen Therapeutics Hottest Chili Goodness, Gracious, Great Balls of Fire--Fairway Medical Best Dressed Team I Dream of Chili--Tanox Best Themed Booth Trailer Park...

2004 Annual Luncheon

Wed, 05 Mar 2008 20:01:54 GMT

Past Annual Luncheons: 2006, 2004 BioHouston held its Members and Associates Annual Meeting on January 27, 2004. More than 100 of our Members, Associates, interested parties and members of the press were in attendance. Chairman R. Bruce LaBoon and President and CEO Jacqueline Northcut Waugh reviewed the 2003 accomplishments and plans for 2004. Chairman LaBoon also announced the more than 40 new Members and Associates that have joined our efforts since last years meeting. The BioHouston 2004 Industry Survey was presented. The survey was performed in late 2003 and gathered data from the life science community in the Houston region and the technology transfer offices of our major research and academic institutions. Also speaking at the meeting on separate parts of the data were: Maria Gorski--Senior Manager, Ernst & Young Malcolm Gillis, Ph.D.--President, Rice University C. Tom Caskey, M.D.--President and CEO, Cogene Biotech Ventures Ernie Cockrell--Chairman, PTV Sciences, LLP...

Terms and Conditions

Mon, 03 Mar 2008 18:50:35 GMT

PLEASE CAREFULLY REVIEW THE TERMS OF USE OF THIS SITE. As your use of the site will indicate your acceptance of these terms, do not use the site if you do not agree to be bound by these terms. We may periodically change the terms, so please check them from time to time as your continued use of the site signifies your acceptance of any changed items. WHILE WE MAKE REASONABLE EFFORTS TO PROVIDE ACCURATE AND TIMELY INFORMATION ABOUT BIOHOUSTON, INC. ON THIS SITE, YOU SHOULD NOT ASSUME THAT THE INFORMATION PROVIDED IS ALWAYS UP TO DATE OR THAT THIS SITE CONTAINS ALL THE RELEVANT INFORMATION AVAILABLE ABOUT BIOHOUSTON. COPYRIGHT AND TRADEMARK. Unless otherwise noted, all materials on this site are protected as the copyrights, trade dress, trademarks and/or other intellectual properties owned by BioHouston and/or its Members and Associates or by other parties that have licensed their material to BioHouston. All rights not expressly granted are reserved. PERSONAL USE. Your use of the...

Events

Fri, 29 Feb 2008 19:51:24 GMT

BioHouston hosts over 60 events each year to nurture the criticial elements required for strong commercial development in Houston. The ultimate goal is to facilitate translational research and technology transfer, enhance capital formation, increase the availability of investment capital, and support technology development and commercialization Texas Life Science Conference November 5, 6, & 7, 2008 The Texas Life Science Conference is Texas premier venture conference, the most comprehensive showcase of cutting edge research and innovative entrepreneurs in the state. With hundreds of national and local venture capitalists in attendance, this conference serves as a vehicle for increasing funding to our community and raise awareness for all that Texas biotech has to offer. Annual Luncheon The Annual Luncheon is attended by the Whos Who of the Houstons life science community and includes keynote addresses from prominent industry leaders. Past Luncheon speakers have...

Programs

Fri, 29 Feb 2008 19:44:40 GMT

BioHouston is a trusted source of information and resources about Houston's biotechnology industry. Our programs and resources help connect people with the information they need about the industry.

Michael E. Debakey Life Science Award

This award is given out annually at our Texas Life Science Conference to recognize an emerging life science company from Texas that has demonstrated exceptional innovation and potential to commercialize an important product. OrthoAccel Technologies, Inc. was the winner of the 2007 Michael E. DeBakey Award and $25,000 cash prize. OrthoAccel Technologies, Inc. designs, develops, and markets a revolutionary device that cuts treatment time for braces in half and works in combination with all existing orthodontia bracket technologies.

Biotech 101

BioHouston's highly successful "Biotech 101" course is being offered every quarter, providing an overview of the science of biotechnology and its applications, the regulatory and business issues associated with commercializing novel biotechnologies, and the international, domestic, and regional biotech industry.

Pharma Matchmaking Meetings

Medical Device 101

Fri, 29 Feb 2008 17:00:55 GMT

March 14, 2008 7:30 AM - 12:00 PM University of Houston M. D. Anderson Library—Elizabeth D. Rockwell Pavilion, Suite 214A 4800 Calhoun Rd. Cost to attend: $50 Paid Parking w/Pre-Registration by February 29, 2008 The mission of the Gulf Coast Medical Device Manufacturers is to establish a community of engineering and manufacturing companies to facilitate and service the commercialization of medical devices in the Houston Gulf Coast region. The GCMDM meets monthly to network and educate each other about the engineering and manufacturing capabilities and opportunities in the region. The GCMDM includes senior management representing tangible engineering or manufacturing services directly involved in the product realization process of medical devices. The roundtable consists of a local community of engineering and manufacturing companies that are working together to commercialize medical devices and life science products developed in the Texas Medical Center and Gulf Coast...

Biotech 101

Fri, 29 Feb 2008 02:50:13 GMT

Biotech 101 provides an overview of the science of biotechnology and its applications, the regulatory and business issues associated with commercializing novel biotechnologies, and the international, domestic, and regional biotech industry.

Five broad biotechnology-related topics are covered in this one-day workshop:

Biotechnology defined, with an introduction to the basic science and terminology associated with the discipline
Applications of biotechnology, with an emphasis on healthcare
Developing a new biotechnology product, from laboratory to market
Business issues associated with commercializing biotechnologies
The Houston-region biotechnology industry

Those who will benefit from this course include:

Employees at life science companies who are new to biotechnology
Economic development professionals
Regional government officials
Consular officials responsible for the life sciences
Media professionals who cover the life sciences
Investors or potential investors in biotechnology companies
Consultants, sales professionals, and service providers who interact with the industry, or who wish to do so
Graduate and undergraduate students interested in biotechnology

If you have any questions, please contact Keisha Curtis at 713-979-9212.

Medical Device 101

Fri, 29 Feb 2008 02:37:44 GMT

Job Listings

Fri, 29 Feb 2008 00:44:48 GMT

The BioHouston website provides job postings for life science-related positions in the Houston/Woodlands/Galveston region. To view available jobs or to post/edit your job posting, please click the link below.

Enter Job Listings Site

If you would like to post your avaiable positions, you must be logged in to add a job. Once you are logged in, you may enter the job listings site and click "Add" under the "Job" tab.

If you have any questions, please contact Tran Tu at tran.tu@biohouston.org or 713.979.9108.

Board--Executive Committee--Ulrich

Wed, 30 Jan 2008 19:39:50 GMT

Robert D. Ulrich, Ph.D.
General Partner, Life Sciences
Vanguard Ventures

Dr. Bob Ulrich is a General Partner investing in the Life Sciences sector at Vanguard. Bob is a seasoned veteran of both the health care industry and venture capital community, earning prominence as a technologist, operating executive, CEO, entrepreneur and venture capital investor.

Prior to joining Vanguard Ventures, Bob was co-founder and President of VanMed, a Vanguard sponsored business incubator specialized in seed stage medical opportunities. He played an active role in several VanMed companies, serving as CEO of five and a Board of Directors member of seven. Bob was President and CEO of Menlo Care, Inc., a spinout of Raychem, which was later acquired by Johnson & Johnson. He served as President and CEO of MedVest, Inc., a medical incubator, responsible for analyzing the business and technology aspects of products for investment and acquisition. Bob's career in the medical industry began at General Electric and continued at Johnson & Johnson where he was Director of New Technologies. In this capacity he directed U.S. and international medical products business development, investments and acquisitions for therapeutic and diagnostic devices and pharmaceuticals. His most notable acquisition was that of the Schatz-Palmaz coronary stent, which has become one of the most successful medical devices in history.

He earned his Bachelor of Arts degree in Physics from Claremont McKenna College, and a Master of Science degree and Ph.D. in Polymer Science and Engineering from the University of Massachusetts.

Bob is a member of the Board of Directors for Capella, Eunoe, HemoSense, Peptimmune, Percardia, TissueLink and Vesalius Ventures. He is an observer on the Board of Directors for CryoCor, BioSeek, Sontra, and Startech.

Board--Executive Committee--Traber

Wed, 30 Jan 2008 19:39:18 GMT

Peter G. Traber, M.D. President & CEO Baylor College of Medicine Peter G. Traber, M.D. is President and Chief Executive Officer of Baylor College of Medicine and Professor of Medicine, positions he has held since March 2003. Dr. Traber has had a long career in academic medicine involved in patient care, education, and research as well as leadership positions in the pharmaceutical industry. Prior to joining Baylor, Dr. Traber served as Senior Vice President for Clinical Development & Medical Affairs and Chief Medical Officer at GlaxoSmithKline where he was responsible for worldwide clinical development programs. Prior to GlaxoSmithKline, Dr. Traber was Chief Executive Officer of the University of Pennsylvania Health System and Interim Dean for the University of Pennsylvania School of Medicine in Philadelphia. He also served as Chair of the Department of Internal Medicine at the school from July 1997 to February 2000. Under his leadership, the Department of Internal Medicine was...

Board--Executive Committee--Shapiro

Wed, 30 Jan 2008 19:38:57 GMT

Marc J. Shapiro
Chairman
Chase Bank of Texas

Marc J. Shapiro retired in 2003 as vice chairman for finance and risk management at J.P. Morgan Chase & Co., to return to his native city of Houston. He currently serves as Non-Executive Chairman of Chase Bank of Texas.

Mr. Shapiro began his banking career at Texas Commerce Bank in 1972, and his progression through the Texas Commerce organization included service as chief financial officer beginning in 1977. In 1989, after the bank was purchased by J.P. Morgan Chase, he was named chief executive officer of the statewide organization. He moved to New York to work for the parent company in 1997.

He serves as a director of Burlington Northern Santa Fe Corporation, Kimberly-Clark Corporation and Weingarten Realty Investors. He is Vice Chairman of the Board of Visitors of the M.D. Anderson Cancer Center and the Board of Baylor College of Medicine and also serves on the boards of BioHouston and Rice University. He is currently co-chairman of the Hobby Center for the Performing Arts and previously served as chairman of the Greater Houston Partnership.

Mr. Shapiro completed his undergraduate work at Harvard with a degree in economics and his MBA studies at Stanford.

Board--Executive Committee--Northcut

Wed, 30 Jan 2008 19:38:37 GMT

Jacqueline R. Northcut
President and CEO

BioHouston, Inc.

Jacqueline joined BioHouston as its President and CEO in December 2002, creating an organization that is the foundation for what BioHouston has become today.

In January of 2004, Jacqueline was appointed by Mayor Bill White of the City of Houston to his Economic Development Task Force, whose mission is to evaluate the public and private economic development efforts in the Houston Region. Jacqueline also sits on the boards of directors of the Houston Technology Center and South Main Center Association.

Prior to joining BioHouston, Jacqueline was an audit partner with Arthur Andersen and was the lead partner for life science companies in Texas. For 18 years, she worked with emerging businesses from the initial start up phase through maturity in various industries including biotechnology, venture capital, medical device and several service industries.

Jacqueline’s passion for life sciences is exemplified by her affiliations, past and present. She was a co-chair for the 2003 Association of Bioscience Financial Officers (ABFO) national conference, and for the previous 12 years, has served as an ABFO host. In 2004 and 2005 she served as the ABFO Conference Advisor.

She is a founder and past board member of the Texas Healthcare & Bioscience Institute, the Southwest Association of Biotechnology Companies and of BioTexas. In addition, she formerly served on the board of the Texas Technology Transfer Association, and was a steering committee member of the BioMedical Technology Club of Houston. Jacqueline also served on the allocations committee for United Way for nine years.

She received her BBS from Harding University in 1984.

Board--Executive Committee--Leebron

Wed, 30 Jan 2008 19:38:19 GMT

David W. Leebron
President
Rice University

David W. Leebron was appointed the seventh President of Rice University in 2004, where he is also Professor of Political Science. He grew up in Philadelphia and graduated summa cum laude from Harvard College in 1976. He attended Harvard Law School, and in his second year was elected President of the Harvard Law Review. After graduating magna cum laude in 1979, he moved to Los Angeles to begin a clerkship with Judge Shirley Hufstedler on the Ninth Circuit Court of Appeals. He also taught torts as an adjunct faculty member at UCLA School of Law.

In 1981, David joined the New York law firm of Cleary, Gottlieb, Steen & Hamilton and specialized in international corporate matters. He became a faculty member of the New York University School of Law in 1983, where he also served as Director of the International Legal Studies Program. In 1989, David joined the faculty of Columbia University School of Law, and in 1996 he was appointed Dean and named the Lucy G. Moses Professor of Law. David has authored a textbook on international human rights and has written numerous articles on issues of international law.

David is married to Y. Ping Sun, a graduate of Columbia Law School, and has two young children, Daniel (8) and Merissa (5).

Additional information is available on President Leebron's curriculum vitae, which can be found at rice.edu/president.

Board--Executive Committee--Currall

Wed, 30 Jan 2008 19:37:54 GMT

Steven C. Currall, Ph.D., Professor and Head (Chair) of Department of Management Science and Innovation, Faculty of Engineering Sciences, University College London; Visiting Professor of Entrepreneurship London Business School (Joint appointment with University College London) Steve Currall is Professor of Management Science and Innovation in the Faculty of Engineering Sciences at University College London (UCL) and Visiting Professor of Entrepreneurship at London Business School (joint with UCL). He is Head (Chair) of the Department of Management Science and Innovation, Founding Director of UCL Advances, and Faculty Co-Director of the Institute of Technology at London Business School. Currall has research, teaching, and advising experience in the areas of emerging technologies, negotiation, and corporate governance. In 2003, he was a Visiting Scholar at the University of Chicago’s Graduate School of Business. His research has been published in both business and science/engineering...

Board--Executive Committee--Given

Wed, 30 Jan 2008 19:37:37 GMT

Bruce D. Given, M.D.

Dr. Given serves as a Healthcare Products Consultant as the Principal of Bruce Given Consulting. Until June of 2007, Dr. Given served as President and Chief Executive Officer and as a member of the Board of Directors of Encysive Pharmaceuticals, which he joined in 2002. Prior to joining Encysive Pharmaceuticals, he was with Johnson & Johnson for 9 years, serving in several capacities including as President, International, Ortho-Clinical Diagnostics and as Group Vice President, Head of U.S. Marketing & Sales, Research & Development for Janssen Pharmaceutica. He has held various executive and senior management positions at Sandoz Pharma Ltd., Sandoz Research Institute and Schering-Plough Corporation. Prior to entering the pharmaceutical industry, he was on the medical faculty at the University of Chicago.

Dr. Given obtained his bachelor of sciences degree from Colorado State University, graduating Phi Beta Kappa. He received his M.D. degree with honors from the University of Chicago, Pritzker School of Medicine and completed his medical training at the University of Chicago and at Brigham and Women’s Hospital in Boston, where he was a Clinical Fellow at Harvard Medical School. He is board certified in internal medicine and endocrinology and metabolism and has authored 33 scientific publications.

Dr.Given serves on the Boards of Directors for ICON Plc and BioHouston, is a member of the Technology Review Committee of MD Anderson Medical Center and is past Chairman of the Rider University Scientific Advisory Board.

Board--Executive Committee--Mendelsohn

Wed, 30 Jan 2008 19:37:15 GMT

John Mendelsohn, M.D., Vice Chairman President The University of Texas M.D. Anderson Cancer Center Dr. John Mendelsohn combines experience in clinical and laboratory research with administrative expertise for guiding The University of Texas M. D. Anderson Cancer Center in the 21st century. Since becoming president in 1996, he has recruited a visionary management team and implemented new priorities for integrated programs in patient care, research, education and cancer prevention. Under his direction, M. D. Anderson has been named the top cancer hospital in the nation four out of the past five years in U.S. News & World Reports Americas Best Hospitals survey. For almost three decades, Dr. Mendelsohn has been at the forefront in understanding how growth factors regulate the proliferation of cancer cells by activating receptors on the surface of the cells. These receptors, when activated, control key cell signaling pathways. He developed a specific monoclonal antibody called Erbitux™,...

Board--Executive Committee--Gillis

Wed, 30 Jan 2008 19:36:55 GMT

Malcolm Gillis, Ph.D. University Professor and Ervin K. Zingler Professor of Economics Rice University Malcolm Gillis spent the first twenty-five years of his professional life teaching economics and bringing economic analysis to bear on important issues of public policy in nearly twenty countries, from the U.S. and Canada to Ecuador, Colombia, Ghana, and Indonesia. Since 1986, his career has been devoted primarily, but not exclusively, to university leadership. His research and teaching activities fall into two broad classes of national and international issues: fiscal reform and environmental policy. He has published over 70 articles in journals. He is author, co-author, or editor of eight books, including a widely acclaimed 1988 publication, Public Policies and the Misuse of Forest Resources and Tax Reform in Developing Countries published in 1989, and the leading textbook in its field, Economics of Development (4th edition), now available in five languages. His record also...

Regulatory Affairs Roundtable

Wed, 30 Jan 2008 19:14:59 GMT

As new drugs and medical devices move through the various phases of development, life science companies face a spectrum of regulatory issues associated with the pursuit of FDA approval and marketing of these products. The Regulatory Affairs Roundtable meetings invite Regulatory Affairs professionals to gather to discuss current regulatory issues and challenges facing their companies; networking is combined with a presentation on a topic with strategic significance to development-stage companies. As many Regulatory Affairs professionals are working in small groups of one or more, this is a chance for them to learn from others in their field.

For more information, please contact Keisha Curtis at 713-979-9212.

For sponsorship information, please contact Lauren Stroman at 713-979-9106.

Occasional Thursdays

Wed, 30 Jan 2008 19:14:39 GMT

Geared toward graduate research and business students, post-doctoral students, junior level faculty and burgeoning entrepreneurs, this series will emphasize networking and education in a “fun” environment. At this event, young entrepreneurs will gather for informal networking while having the opportunity to listen to and interact with seasoned industry experts who will share their insights and experiences. Don’t miss this great opportunity to hear from an industry expert about his entrepreneurial experiences and network with the Houston biotech community.

The steps to transition early-stage technologies out of the laboratory and into a commercial venture are much more complex than simply carrying out the mechanics of technology transfer. Challenges abound, including finding funding, and making this funding go as far as possible. Come hear an overview of the early technology evaluation, licensing, and product-development process for life science technologies. Also, learn about the BioHouston Resource Center, a wet laboratory facility that is designed to give academic entrepreneurs and start-ups access to the resources they need to develop their projects and generate data that will set them on the road to commercial success.

For more information, please contact Keisha Curtis at 713.979.9212.

For sponsorship information, please contact Lauren Stroman at 713.979.9106.

Associates I

Sat, 05 Jan 2008 00:26:05 GMT

Agennix, Inc. AlphaDev AptaMed BioCentury Publications, Inc. BioTex, Inc. Brand Institute, Inc. CAP Resources Centerpoint Energy Clear Financial Solutions, Inc. Colliers International CryoGene Cypressbrook Company DataMatrix, Inc. DeWalch Technologies Di Pure Water Technologies DNA Bridges, Inc. Economic Development Alliance for Brazoria County Endothelix, Inc. Epstein Becker Green Wickliff & Hall, P.C. Fairway Medical Technologies, Inc. Frost Bank GeneExcel, Inc. Gensler Greater Fort Bend Economic Development Council Greater Houston Partnership Greenharbor Medical Corp. Halsa Pharmaceuticals The Harrington Law Firm Houston Angel Network Houston Business Journal Houston Minority Business Council Houston Technology Center IDev Technologies, Inc. InGeneron, Inc. inVentiv Clinical J.E. Dunn Southwest JETRO Houston Kirksey Kodiak Thermal Technologies, Inc. Korn/Ferry International La Jolla Capital Partners LifeCap Resources Linbeck Linda...